|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.90 USD | -0.06% |
|
-3.27% | +8.11% |
| 05:04pm | UBS Raises Price Target on Pfizer to $27 From $25, Maintains Neutral Rating | MT |
| 01:58pm | Earnings Season in Trump's Shadow |  |
| Capitalization | 153B 131B 121B 114B 212B 14,339B 217B 1,413B 555B 6,848B 575B 562B 24,461B | P/E ratio 2026 * |
12.2x | P/E ratio 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise value | 199B 170B 157B 148B 275B 18,626B 282B 1,835B 722B 8,895B 746B 731B 31,774B | EV / Sales 2026 * |
3.24x | EV / Sales 2027 * | 3.3x |
| Free-Float |
59.04% | Yield 2026 * |
6.53% | Yield 2027 * | 6.52% |
Last Transcript: Pfizer Inc.
| 1 day | -0.02% | ||
| 1 week | -3.27% | ||
| Current month | -4.13% | ||
| 1 month | +1.28% | ||
| 3 months | +7.04% | ||
| 6 months | +8.86% | ||
| Current year | +8.11% |
| 1 week | 26.68 |  | 27.68 |
| 1 month | 26.44 | | 28.74 |
| Current year | 24.83 | | 28.74 |
| 1 year | 21.87 | | 28.74 |
| 3 years | 20.92 | | 41.71 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 31/12/2018 |
David Denton
DFI | Director of Finance/CFO | 61 | 01/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 23/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 31/08/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 26/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 31/12/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -8.90% | 14.74% | 253 M€ | |
| -1.82% | 9.37% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.06% | -3.27% | +21.70% | -35.09% | 153B | |
| -1.23% | +0.30% | +23.26% | +147.86% | 841B | |
| -1.20% | -2.24% | +52.62% | +41.82% | 574B | |
| -2.21% | -1.46% | +13.72% | +25.19% | 368B | |
| +0.32% | -0.75% | +29.45% | +14.60% | 320B | |
| -1.59% | +0.20% | +45.23% | +25.78% | 318B | |
| -1.74% | -1.23% | +50.76% | +3.27% | 300B | |
| -0.94% | +0.68% | +35.93% | +38.47% | 295B | |
| -1.42% | +0.98% | +17.70% | +37.58% | 189B | |
| -0.94% | -1.71% | +29.33% | +65.41% | 173B | |
| Average | -1.08% | -0.85% | +31.97% | +36.49% | 353.1B | |
| Weighted average by Cap. | -1.16% | -0.62% | +32.91% | +55.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.3B 52.37B 48.29B 45.57B 84.68B 5,740B 86.83B 566B 222B 2,741B 230B 225B 9,792B | 58.9B 50.32B 46.4B 43.79B 81.37B 5,516B 83.43B 543B 214B 2,634B 221B 216B 9,409B |
| Net income | 12.04B 10.28B 9.48B 8.95B 16.63B 1,127B 17.05B 111B 43.66B 538B 45.17B 44.22B 1,923B | 11.59B 9.9B 9.13B 8.61B 16B 1,085B 16.41B 107B 42.02B 518B 43.48B 42.56B 1,851B |
| Net Debt | 45.78B 39.11B 36.06B 34.03B 63.24B 4,287B 64.85B 422B 166B 2,047B 172B 168B 7,313B | 40.97B 35B 32.27B 30.46B 56.6B 3,837B 58.03B 378B 149B 1,832B 154B 151B 6,545B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/04/26 | 26.90 $ | -0.09% | 12,579,350 |
| 10/04/26 | 26.92 $ | -1.10% | 27,882,376 |
| 09/04/26 | 27.22 $ | -0.91% | 27,047,559 |
| 08/04/26 | 27.47 $ | +1.37% | 33,789,069 |
| 07/04/26 | 27.10 $ | -2.62% | 46,620,512 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition